In this one hour special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Miller. If you’ve worked in the bio and pharmaceutical CDMO space for a few years, then there’s a very good chance you will know my guest today. Jim is a renowned expert in the space and a regular speaker at all the major trade conferences including CPhI WW. He made his name in the sector after founding and growing PharmSource with his wife Judy, an online database on bio/pharmaceutical intelligence, before selling the business to Global Data. Today, he’s an industry consultant and regularly writes for leading industry publications like DCAT and Pharmaceutical Technology.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering how his husband & wife start-up business helped put the industry on the map while providing CMOs/CDMOs with invaluable drug pipeline intel. He explains how CDMOs have enabled the success of the explosion of emerging biopharma in the last 10 years, helping them turn IP into product. He also gives his expert take on the changing role of CDMOs in Asia and whether we will see any APIs bounce back to North America and Europe. Lastly he covers the robustness of the market post Covid-19 and whether to expect to see a financial dip or not.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.